Concepedia
Statistics
Publications
2
Citations
85
H-Index
Active since
2016
Affiliations
Eli Lilly (United Kingdom)(Current)
DaVita Clinical Research (United States)
Orlando Clinical Research Center
Indiana University – Purdue University Indianapolis
Eli Lilly (United States)
Philip Barrington is an author at Eli Lilly (United Kingdom) specializing in chronic kidney disease, ferroportin function, and anemia.
Publications per year
2016–2019
Targeting the hepcidin–ferroportin pathway in anaemia of chronic kidney disease
Matthew J. Sheetz, Philip Barrington, Sophie Callies et al. · British Journal of Clinical Pharmacology · 2019 · 75 citations · Full text
Medicine, Molecular Medicine, Nephrology +17
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Anti-Ferroportin Antibody in Patients with Anemia Due to Chronic Renal Failure
Philip Barrington, Matthew J. Sheetz, Sophie Callies et al. · Blood · 2016 · 10 citations
Medicine, Clinical Pharmacokinetics, Pharmacokinetics +16
1–2 of 2